QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute of Molecular Pathology (“IMP”), both located in Vienna, Austria.
Company Details
- Employees
- 17
- Founded
- -
- Address
- Dr. Bohr-Gasse 7, Vienna,1030,austria
- Phone
- +43 122 66001-20
- of****@****-tx.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- quantro-tx.com
- HQ
- Vienna
Quantro Therapeutics Gmbh Questions
Quantro Therapeutics Gmbh's helpline number is +43 122 66001-20
Quantro Therapeutics Gmbh's website is quantro-tx.com
Quantro Therapeutics Gmbh's LinkedIn profile is https://at.linkedin.com/company/quantro-therapeutics
Quantro Therapeutics Gmbh has
17 employees.
View email and phone details for 17
employees at Quantro Therapeutics Gmbh.
Quantro Therapeutics Gmbh's industry is
Pharmaceutical Manufacturing
Quantro Therapeutics Gmbh's top competitors are
Proxygen,
G.st Antivirals,
Ablevia Biotech Gmbh,
Heartbeat.bio Ag,
Sarcura,
A:head Bio Ag,
Valanx Biotech,
Ribbon Bio,
Myllia Biotechnology,
Lexogen.
Quantro Therapeutics Gmbh's support email address is office@quantro-tx.com
Quantro Therapeutics Gmbh's categories are Pharmaceutical Manufacturing
Quantro Therapeutics Gmbh's founding year is 2019
